{"SPADE_UN_01630": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2007/0185019 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2007_0185019_A1", "Patent Type": "Patent Application", "Publication Date": "2007-8-9", "Family Info": "CA2523998A1,CN1791612A,CN100362017C,CN101161284A,CN101161284B,EP1625155A1,EP1625155B1,US20090074864,WO2005061535A1", "Patent Title": "Novel antimicrobial peptides with heparin binding activity.", "Abstract": "The invention relates to an antimicrobial peptide with heparin binding activity, being derived from endogenous mammalian proteins being substantially free from antimicrobial activity selected from the group consisting of laminin isoforms, complement factor C3, histidin rich glycoprotein and kininogen and having from 10 to 36 amino acid residues, wherein the antimicrobial peptide consists of at least four amino acid residues selected from the group consisting of K, R and H. The invention also relates to pharmaceutical compositions comprising said antimicrobial peptide and use of the antimicrobial peptide and/or antimicrobial/pharmaceutical composition."}], "Sequence Information": {"SPADE ID": "SPADE_UN_01630", "Sequence": "RIQNLLKITNLRIKFVKL", "Sequence Length": 18, "Peptide Name": "Sequence 16 from Patent US 20070185019", "Source": "Synthetic construct", "Biological Activity": ["Antimicrobial"], "Frequent Amino Acids": "LIK", "Absent Amino Acids": "ACDEGHMOPSUWY", "Basic Residues": 5, "Acidic Residues": 0, "Hydrophobic Residues": 9, "Polar Residues": 10, "Positive Residues": 5, "Negative Residues": 0, "Mass": 2210.75, "PI": 12.0, "Net Charge": 5, "Hydrophobicity": 0.21, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_04060", "Similarity": 1.0, "Sequence": "KFVKLILAY"}, {"SPADE_ID": "SPADE_N_09182", "Similarity": 0.8333333333333334, "Sequence": "GLLKRIKNLL"}, {"SPADE_ID": "SPADE_UN_27508", "Similarity": 0.8333333333333334, "Sequence": "GLLKRIKNLL"}]}}}